Evidence map›Paper›PMID 37848875›Full record

ArticleHarm reduction journal2023

A qualitative assessment of key considerations for drug checking service implementation.

Chloe Grace Rose, A Simon Pickard, Victoria Kulbokas, Stacey Hoferka, Kaitlyn Friedman, Jennifer Epstein, Todd A Lee

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chloe Grace RoseDepartment of Pharmacy Systems, Outcomes, and Policy, University of Illinois Chicago, 833 S Wood St, Chicago, IL, 60612, USA.
A Simon PickardDepartment of Pharmacy Systems, Outcomes, and Policy, University of Illinois Chicago, 833 S Wood St, Chicago, IL, 60612, USA. pickard1@uic.edu.
Victoria KulbokasDepartment of Pharmacy Systems, Outcomes, and Policy, University of Illinois Chicago, 833 S Wood St, Chicago, IL, 60612, USA.
Stacey HoferkaOffice of Policy, Planning, and Statistics, Illinois Department of Public Health, 122. S. Michigan Ave, 7th Floor, Chicago, IL, 60603, USA.
Kaitlyn FriedmanOffice of Policy, Planning, and Statistics, Illinois Department of Public Health, 122. S. Michigan Ave, 7th Floor, Chicago, IL, 60603, USA.
Jennifer EpsteinOffice of Policy, Planning, and Statistics, Illinois Department of Public Health, 122. S. Michigan Ave, 7th Floor, Chicago, IL, 60603, USA.
Todd A LeeDepartment of Pharmacy Systems, Outcomes, and Policy, University of Illinois Chicago, 833 S Wood St, Chicago, IL, 60612, USA.
University of Illinois Chicago · USIllinois Department of Public Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith many drug-related deaths driven by potent synthetic opioids tainting the illicit drug supply, drug checking services are becoming a key harm reduction strategy. Many drug checking technologies are available, ranging from fentanyl test strips to mass spectrometry. This study aimed to identify key considerations when implementing drug checking technologies and services to support harm reduction initiatives.

methodsKey informant interviews were conducted with harm reduction stakeholders throughout Illinois. Participants included members of existing drug checking services and recovery centers. Interviews were recorded, transcribed, and coded by two researchers using the framework method. Findings were contextualized according to micro (client)-, meso (organization)-, and macro (policy)-level themes.

resultsSeven interviews were conducted with ten participants. Fourier transform infrared spectroscopy was consistently identified as a technology of choice given its accuracy, range of substance detection, portability, and usability. Recommendations included the use of confirmatory testing, which can help address the limitations of technologies and provide a mechanism to train technicians. Locations of drug checking services should maximize public health outreach and leverage existing harm reduction agencies and staff with lived experience, who are critical to developing trust and rapport with clients. Criminalization and loss of privacy were major concerns for clients using drug checking services. Additional issues included the need to raise awareness of the legitimacy of services through public support from governing bodies, and funding to ensure the sustainability of drug checking services.

conclusionsThis research facilitated the identification of issues and recommendations from stakeholders around key considerations for the adoption of drug checking technologies, which not only included the cost and technical specifications of instrumentation, but also broader issues such as accessibility, privacy, and well-trained personnel trusted by clients of the service. Successful implementation of drug checking services requires knowledge of local needs and capacity and an in-depth understanding of the target population.

Indexed as

Drug OverdoseIllicit DrugsAnalgesics, OpioidFentanylHarm ReductionHumansPublic HealthAnalgesics, OpioidFentanylIllicit DrugsDrug checkingDrug checking serviceHarm reductionOpioids

Identifiers

PMID37848875
PMCPMC10580636
OpenAlexW4387695797

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.